Deutsches Referenzzentrum für Ethik in den Biowissenschaften (DRZE)

Titel: Cell Culture Engineering X

Termin: 23.4.2006, 16:30 Uhr, bis 28.4.2006, 12:00 Uhr

Veranstaltungsort:
Fairmont Chateau Whistler Ski Resort & Spa
Whistler, British Columbia, Canada

Referenten: Abhinav A. Shukla (Amgen Inc. USA) *** Ajaz Hussain (Sandoz, USA) *** Alice S. Chuck (Amgen, USA) *** Alvin W. Nienow (University of Birmingham, UK) *** Amine Kamen (Biotechnology Research Institute, Canada) *** Annie De Groot (Brown Medical School and EpiVax, USA) *** Barry Morse (Centocor Research and Development, Inc., USA) *** Carole Heath (Amgen, USA) *** Charles Goochee (Merck / Amgen, USA) *** Charles Haynes (University of British Columbia, Canada) *** Christopher J. Mann (Genetix, United Kingdom) *** Dale L. Ludwig (ImClone Systems Incorporated, USA) *** Dana Andersen (Genentech, USA) *** David C. James (University of Queensland, Australia) *** Dhinakar S. Kompala (University of Colorado, USA) *** E. Terry Papoutsakis (Northwestern University, USA) *** Eric Jervis (University of Waterloo, Canada) *** Florian Wurm (EPFL, Switzerland) *** Francesc Gòdia (Universitat Autonoma de Barcelona, Spain) *** Friedrich Srienc (University of Minnesota, USA) *** Gary Lye (University College London, UK) *** Georg Schmid (Hoffmann-La Roche, Switzerland) *** Georgyi V. Los (Promega Corporation, USA) *** Glyn N. Stacey (UK Stem Cell Bank, NIBSC, UK) *** Haley A. Laken (Wyeth BioPharma, USA) *** Hansjörg Hauser (GBF, Germany) *** Hazel Thomson (Stem Cell Sciences (UK) Ltd., UK) *** Heidi Trusheim (Chiron Vaccines, Germany) *** Helena Yusuf Makagiansar (Biogen Idec Inc., USA) *** Ilse Blumentals (GlaxoSmithKline, USA) *** Janice A. Phillips (Centocor, Inc. /GBSC, LLC, USA) *** Jeffrey Chalmers (Ohio State University, USA) *** Jens Vogel (Bayer HealthCare, USA) *** John Aunins (Merck, USA) *** Judy H. Chou (Wyeth Biopharma, USA) *** Kelvin H. Lee (Cornell University, USA) *** Laura A. Palomares (UNAM, Cuernavaca, Mexico) *** Linda M. Hendershot (St. Jude Children's Research Hospital, USA) *** Lynne Krummen (Genentech, USA) *** Malcolm Kennard (Chromos, Canada) *** Manuel J.T. Carrondo (IBET/ITQB, FCT/UNL, Portugal) *** Martin Fussenegger (ETH Zurich, Switzerland) *** Martin Gawlitzek (Genentech, Inc., USA) *** Martin Pera (Monash University & the Australian Stem Cell Centre) *** Martin S. Sinacore (Wyeth BioPharma, USA) *** Matthew Caple (Sigma, USA) *** Michael Butler (University of Manitoba, Canada) *** Michael Howaldt (Boehringer Ingelheim, Germany) *** Mohamed Al-Rubeai (University College Dublin, Ireland) *** Nedim E. Altaras (Merck & Co., USA) *** Nicole Borth (IAM, University of Applied Life Sciences, Austria) *** Nigel Jenkins (Serono, Switzerland) *** Noelle-Anne Sunstrom (ACYTE Biotech, Australia) *** Ola Tuvesson (Global Protein Science & Supply, AstraZeneca Södertälje, Sweden) *** Peter Zandstra (University of Toronto, Canada) *** Philip Lester (Genentech Inc., USA) *** Robert Deans (Athersys, USA) *** Robert Kiss (Genentech, Inc., USA) *** Roderick W Geldart (Amgen, USA) *** Rohini Deshpande (Amgen, Inc., USA) *** Sharon Gerecht (Massachusetts Institute of Technology, USA) *** Sigma S. Mostafa (Eli Lilly & Company, USA) *** Steven Burrill (Burrill & Company, USA) *** Steven Cramer (Rensellear Polytechnic Institute, USA) *** Steven Max (Wyeth BioPharma, USA) *** Thomas Scheper (U. Hannover, Germany) *** Tim Charlebois (Wyeth BioPharma, USA) *** Udo Reichl (Max Planck Institute for Dynamics of Complex Technical Systems, Germany) *** Ulrich Valley (Chiron, Germany) *** Weichang Zhou (PDL BioPharma, Inc., USA) *** Wei-Shou Hu (University of Minnesota, USA) *** William Miller (Northwestern University, USA)

Weitere Informationen:
http://www.engconfintl.org/6ac.html

Kurzbeschreibung: Since the 1980s, animal cell culture technology has become essential for the production of an ever increasing number of human and veterinary biopharmaceuticals. These bi-annual Cell Culture Engineering conferences are a leading venue for the academic, industrial and regulatory communities to learn and debate new concepts and issues related to animal cell culture research and development. The 10th anniversary of this highly successful conference series will be held at the top-ranked Whistler mountain resort.

This 2006 meeting will celebrate our conference tradition of high quality and relevance to both industrial and academic participants, with topics ranging from the frontiers of fundamental science to the engineering challenges of cell culture process development.

Kontakt: Engineering Conferences International
6 Metro Tech Center
Brooklyn, NY 11201
USA
Tel.: +1 - 718 - 2 60 37 43
Fax: +1 - 718 - 2 60 37 54
info@eci.poly.edu
http://www.engconfintl.org/

Veranstalter: ECI Engineering Conferences International

Schlagworte: Embryonale Stammzellen, Embryonenforschung, Eugenik/Enhancement, Genetische Tests/Beratung, Genforschung/-technik, Genomanalyse, Humangenetik, Klonierung, Organ-/Gewebetransplantation, Tierethik

Artikelaktionen